Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Effect of Other Antipsychotics and Neuroleptics”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Post-approval studies (Phase 4)WithdrawnNCT01567124
What this trial is testing

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Who this might be right for
Schizophrenia
Baker Heart and Diabetes Institute
Not applicableUnknownNCT00752960
What this trial is testing

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

Who this might be right for
Psychoses
Genomas, Inc 1,000
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableStudy completedNCT06326840
What this trial is testing

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

Who this might be right for
Metabolic DisturbanceHyperprolactinemiaSchizophrenia
Taipei Medical University Hospital 42
Not applicableStudy completedNCT00363181
What this trial is testing

Side Effects of Antipsychotic Medications

Who this might be right for
Insulin ResistanceMetabolic Syndrome XSchizophrenia and Disorders With Psychotic Features+2 more
Stanford University 76
Not applicableUnknownNCT02205437
What this trial is testing

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Fundación Marques de Valdecilla 200
Not applicableStudy completedNCT02604056
What this trial is testing

Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing

Who this might be right for
Adverse Effect of Other Antipsychotics and Neuroleptics
Women's College Hospital 60
Not applicableStudy completedNCT01739127
What this trial is testing

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Who this might be right for
Psychotic DisordersBipolar DisorderMetabolic Syndrome X
University of British Columbia 83
Not applicableStudy completedNCT00815854
What this trial is testing

Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

Who this might be right for
Schizophrenia
University of Michigan 88
Not applicableLooking for participantsNCT05951660
What this trial is testing

Sex, Psychopharmacology, and Diabetes

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersDiabetes Mellitus+4 more
Zealand University Hospital 256
Post-approval studies (Phase 4)Study completedNCT01811160
What this trial is testing

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Who this might be right for
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Not applicableStudy completedNCT00206960
What this trial is testing

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 56
Not applicableStudy completedNCT02582736
What this trial is testing

Antipsychotics and Risk of Hyperglycemic Emergencies

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
Canadian Network for Observational Drug Effect Studies, CNODES 725,489
Post-approval studies (Phase 4)Study completedNCT01050582
What this trial is testing

Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Who this might be right for
SchizophreniaBipolar DisorderAutistic Disorder+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244
Post-approval studies (Phase 4)Study completedNCT00245206
What this trial is testing

Side Effects of Newer Antipsychotics in Older Adults

Who this might be right for
SchizophreniaAlzheimer's DiseaseDementia
Veterans Medical Research Foundation 406
Post-approval studies (Phase 4)Study completedNCT00682448
What this trial is testing

Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

Who this might be right for
Metabolic Complications
Rush University Medical Center 25
Large-scale testing (Phase 3)Study completedNCT00419146
What this trial is testing

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University Hospital, Aker 99
Not applicableLooking for participantsNCT06624462
What this trial is testing

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Who this might be right for
Severe Mental DisorderMetabolic ComplicationSide-Effect;Medication+2 more
Bjorn H. Ebdrup 84
Next Page